Skip to main content
PRECIGEN, INC. logo

PRECIGEN, INC. — Investor Relations & Filings

Listed
Ticker · PGEN ISIN · US46122T1025 LEI · 549300XCWNQU35K64G19 US Manufacturing
Open in API
Filings indexed 1,170 across all filing types
Latest filing 2026-06-24 Declaration of Voting R…
Country US United States of America
Listing US PGEN · 10 venues

About PRECIGEN, INC.

https://precigen.com/

Precigen, Inc. is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation gene and cell therapies. The company utilizes precision technology to create highly targeted medicines for difficult-to-treat diseases. Its primary therapeutic areas of focus include immuno-oncology and autoimmune disorders. Precigen aims to provide innovative treatments for patients with significant unmet medical needs by advancing its portfolio of precision medicines.

Recent filings

Filing Released Lang Actions
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 18, 2026. It contains information about stockholder voting results from an Annual Meeting, including election of directors, ratification of auditors, approval of executive compensation, and approval of an amendment to a stock incentive plan. The text includes detailed vote counts for each proposal and references to prior proxy statements. The key part is Item 5.07, which covers submission of matters to a vote of security holders, reporting the official voting results. The report also includes a section on departure or appointment of officers/directors (Item 5.02). Since the primary content focuses on official voting results from the Annual Meeting, including elections and approvals by shareholders, this aligns with the category 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length (6,764 characters) is sufficient to contain the full voting results rather than a brief announcement. Therefore, it is classified as DVA with high confidence.
2026-06-24 English
AGM 2026
Call Transcript Classification · 100% confidence
2026-06-18 English
Goldman Sachs 47th Annual Global Healthcare Conference 2026
Call Transcript Classification · 100% confidence
2026-06-08 English
Q1 2026
Call Transcript Classification · 100% confidence
2026-05-13 English
8-K - PRECIGEN, INC. (0001356090) (Filer)
Regulatory Filings Classification · 85% confidence The document is a Form 8-K “Current Report” filed with the SEC to report material corporate events (Item 2.02 results of operations). It does not contain full financial statements or an investor presentation. It is a routine regulatory filing reporting a press release exhibit. Under the taxonomy, general SEC filings that don’t fit other specific categories classify as Regulatory Filings (RNS).
2026-05-13 English
ARS - PRECIGEN, INC. (0001356090) (Filer)
Annual Report
2026-04-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.